Physician profile
Samuel Lance
NPI 1780811786
$1,814.02
in general payments reported to CMS, 2019-2025
16 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $51.68 · 2021: $365 · 2022: $52.49 · 2023: $223 · 2024: $147 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.93 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $351.56 | 2021 | |
| Depuy Synthes Sales INC. | $350.80 | 2019-2025 | Na, Trumatch |
| Integra Lifesciences Corporation | $292.52 | 2021-2024 | Integra, Acell, Primatrix |
| Abbvie INC. | $221.24 | 2023-2025 | |
| Motiva USA, LLC | $142.04 | 2025 | |
| Allergan, INC. | $140.11 | 2019 | |
| Derma Sciences, INC. | $83.73 | 2019 | |
| Kls-Martin L.P. | $51.28 | 2019-2023 | |
| Misonix INC | $39.78 | 2019-2020 | |
| Pylant Medical | $38.88 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $27.05 | 2025 | Exparel |
| Apyx Medical Corporation | $25.79 | 2020 | |
| Innovation Technologies INC | $16.28 | 2022 | |
| Galderma Laboratories, L.P. | $15.20 | 2022 | |
| Stryker Corporation | $12.10 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ppod Orthotics INC. | $5.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Lance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.